Dr. Greg Riely: How Should We Approach Acquired Resistance to Targeted Therapies in Advanced NSCLC?

Medicina, #acquired, #cancergrace, #clinically, #egfr, #grace, #gracecast, #indolent, #inhibitor, #metastasis, #oligoprogression, #progression, #resistance, #significant, #solitary, #t790m, #tki